Differences in global scientific production between new mRNA and conventional vaccines against COVID-19
MA Ruiz-Fresneda, R Ruiz-Pérez… - … Science and Pollution …, 2022 - Springer
The search for effective vaccines to stop the COVID-19 pandemic has led to an
unprecedented amount of global scientific production and activity. This study aimed to …
unprecedented amount of global scientific production and activity. This study aimed to …
Phytomolecules repurposed as Covid-19 inhibitors: opportunity and challenges
V Chandramouli, SK Niraj, KG Nair, J Joseph… - Current …, 2021 - Springer
The SARS-CoV-2 virus has spread worldwide to cause a full blown pandemic since 2020.
To date, several promising synthetic therapeutics are repurposed and vaccines through …
To date, several promising synthetic therapeutics are repurposed and vaccines through …
Modelling the structural and reactivity landscapes of tucatinib with special reference to its wavefunction-dependent properties and screening for potential antiviral …
HER-2 type breast cancer is one of the most aggressive malignancies found in women.
Tucatinib is recently developed and approved as a potential medicine to fight this disease. In …
Tucatinib is recently developed and approved as a potential medicine to fight this disease. In …
Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria
Abstract Background As of April 23, 2021, more than 145 million cases and almost 3.07
million related deaths were noted because of the coronavirus (Covid-19) Pandemic …
million related deaths were noted because of the coronavirus (Covid-19) Pandemic …
Adverse drug reactions associated with COVID-19 management
V Chavda, P Dodiya, V Apostolopoulos - … -Schmiedeberg's Archives of …, 2024 - Springer
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
outbreak, which causes COVID-19, had a devastating impact on both people's lives and the …
outbreak, which causes COVID-19, had a devastating impact on both people's lives and the …
Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale
Background COVID-19 associated acute respiratory distress syndrome (CARDS) is a severe
form of SARS CoV-2 infection and affects about 15–30% of hospitalized patients with a high …
form of SARS CoV-2 infection and affects about 15–30% of hospitalized patients with a high …